Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related ...
Keaton Herzer tells PEOPLE he struggled accepting help after his cousin volunteered to donate part of her liver to save his ...
Jasmine Jones received the donated organs after spending years living with cystic fibrosis, according to CBS Chicago. She ...
Scientists at The Hormel Institute say they have made new discoveries about a protein that could play a key role in how liver ...
Preview ASCO 2026 late-breaking cancer trials—from TNBC ADC survival gains to lung, liver, prostate and myeloma readouts ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced new retrospective data showing that Noetik’s artificial intelligence-based TARIO-2 model identified spatial tumor ...
EMERALD-3: Phase III trial of IMFINZI ® (durvalumab) in combination with IMJUDO ® (tremelimumab-actl), with or without lenvatinib, and transarterial chemoembolization (TACE) in patients with ...
The human body has some brutal survival limits, and medicine has documented them in detail. Certain body parts can be removed ...
Study Published in Advances in Redox Research Demonstrated Dose-Dependent Survival Improvement, Reduced Hepatic Copper ...
Compared to people without liver steatosis, those with the condition had greater noncalcified coronary plaque burden and ...
The FDA has approved the antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd; Datroway) for adult patients with ...
AstraZeneca advances its ambition to eliminate cancer as a cause of death and transform outcomes for people living with rare diseases with new data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results